Structure

Physi-Chem Properties

Molecular Weight:  393.19
Volume:  408.58
LogP:  4.35
LogD:  3.45
LogS:  -4.636
# Rotatable Bonds:  4
TPSA:  40.16
# H-Bond Aceptor:  5
# H-Bond Donor:  0
# Rings:  5
# Heavy Atoms:  5

MedChem Properties

QED Drug-Likeness Score:  0.608
Synthetic Accessibility Score:  3.021
Fsp3:  0.417
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Rejected
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.109
MDCK Permeability:  3.394926534383558e-05
Pgp-inhibitor:  0.879
Pgp-substrate:  0.992
Human Intestinal Absorption (HIA):  0.002
20% Bioavailability (F20%):  0.011
30% Bioavailability (F30%):  0.059

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.934
Plasma Protein Binding (PPB):  70.59446716308594%
Volume Distribution (VD):  1.341
Pgp-substrate:  17.703454971313477%

ADMET: Metabolism

CYP1A2-inhibitor:  0.388
CYP1A2-substrate:  0.984
CYP2C19-inhibitor:  0.101
CYP2C19-substrate:  0.943
CYP2C9-inhibitor:  0.007
CYP2C9-substrate:  0.834
CYP2D6-inhibitor:  0.951
CYP2D6-substrate:  0.928
CYP3A4-inhibitor:  0.075
CYP3A4-substrate:  0.913

ADMET: Excretion

Clearance (CL):  9.777
Half-life (T1/2):  0.352

ADMET: Toxicity

hERG Blockers:  0.463
Human Hepatotoxicity (H-HT):  0.245
Drug-inuced Liver Injury (DILI):  0.921
AMES Toxicity:  0.595
Rat Oral Acute Toxicity:  0.73
Maximum Recommended Daily Dose:  0.915
Skin Sensitization:  0.946
Carcinogencity:  0.119
Eye Corrosion:  0.004
Eye Irritation:  0.029
Respiratory Toxicity:  0.966

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC244112

Natural Product ID:  NPC244112
Common Name*:   (+)-(S)-13Abeta-Isotylocrebrine
IUPAC Name:   (13aS)-3,4,6,7-tetramethoxy-9,11,12,13,13a,14-hexahydrophenanthro[9,10-f]indolizine
Synonyms:  
Standard InCHIKey:  ZRGRTHUWZSWRSQ-AWEZNQCLSA-N
Standard InCHI:  InChI=1S/C24H27NO4/c1-26-20-8-7-15-16-10-14-6-5-9-25(14)13-19(16)17-11-21(27-2)22(28-3)12-18(17)23(15)24(20)29-4/h7-8,11-12,14H,5-6,9-10,13H2,1-4H3/t14-/m0/s1
SMILES:  COc1cc2c(cc1OC)c1CN3CCC[C@H]3Cc1c1c2c(OC)c(OC)cc1
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL520783
PubChem CID:   12304631
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0002448] Benzenoids
      • [CHEMONTID:0000025] Phenanthrenes and derivatives
        • [CHEMONTID:0001906] Phenanthroindolizidines

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO33385 cynanchum vincetoxicum Species Apocynaceae Eukaryota n.a. n.a. n.a. PMID[11087617]
NPO33385 cynanchum vincetoxicum Species Apocynaceae Eukaryota n.a. n.a. n.a. PMID[12350151]
NPO8035 Tylophora tanakae Species Apocynaceae Eukaryota n.a. n.a. n.a. PMID[12350151]
NPO8035 Tylophora tanakae Species Apocynaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. IC50 = 43.0 nM PMID[543920]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. IC50 = 54.0 nM PMID[543920]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC244112 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9586 High Similarity NPC130941
0.9521 High Similarity NPC219162
0.9384 High Similarity NPC90844
0.9384 High Similarity NPC253883
0.9384 High Similarity NPC95075
0.9211 High Similarity NPC476572
0.9205 High Similarity NPC325871
0.9205 High Similarity NPC99659
0.9167 High Similarity NPC150879
0.9145 High Similarity NPC186063
0.9128 High Similarity NPC92541
0.9103 High Similarity NPC24264
0.9103 High Similarity NPC476432
0.9073 High Similarity NPC26601
0.9045 High Similarity NPC247389
0.9038 High Similarity NPC167546
0.9038 High Similarity NPC225774
0.9038 High Similarity NPC302527
0.9038 High Similarity NPC16805
0.9032 High Similarity NPC60186
0.9007 High Similarity NPC81733
0.9007 High Similarity NPC326316
0.8993 High Similarity NPC144863
0.8981 High Similarity NPC219341
0.8974 High Similarity NPC233650
0.8954 High Similarity NPC76079
0.8924 High Similarity NPC210918
0.8917 High Similarity NPC134858
0.8896 High Similarity NPC477133
0.8896 High Similarity NPC477132
0.8874 High Similarity NPC211296
0.8846 High Similarity NPC160298
0.8846 High Similarity NPC232924
0.8846 High Similarity NPC306902
0.8846 High Similarity NPC266753
0.8846 High Similarity NPC477559
0.8831 High Similarity NPC123323
0.8805 High Similarity NPC474931
0.8805 High Similarity NPC306555
0.8805 High Similarity NPC81218
0.8805 High Similarity NPC158376
0.8805 High Similarity NPC205421
0.8805 High Similarity NPC117188
0.8805 High Similarity NPC12053
0.8805 High Similarity NPC145832
0.8805 High Similarity NPC210140
0.8797 High Similarity NPC136508
0.8797 High Similarity NPC78222
0.8797 High Similarity NPC13504
0.8797 High Similarity NPC196447
0.8797 High Similarity NPC306843
0.8797 High Similarity NPC96603
0.8797 High Similarity NPC212794
0.8797 High Similarity NPC477563
0.8797 High Similarity NPC253043
0.8758 High Similarity NPC19520
0.8758 High Similarity NPC149090
0.8742 High Similarity NPC51957
0.8742 High Similarity NPC16107
0.8742 High Similarity NPC210437
0.8742 High Similarity NPC476144
0.8742 High Similarity NPC106295
0.8734 High Similarity NPC324144
0.8716 High Similarity NPC328750
0.8716 High Similarity NPC213206
0.8716 High Similarity NPC188163
0.8716 High Similarity NPC474915
0.8696 High Similarity NPC6152
0.8684 High Similarity NPC7467
0.8679 High Similarity NPC169743
0.8659 High Similarity NPC320223
0.8659 High Similarity NPC114364
0.8654 High Similarity NPC203784
0.8654 High Similarity NPC170503
0.8654 High Similarity NPC126519
0.865 High Similarity NPC199465
0.865 High Similarity NPC128560
0.865 High Similarity NPC229166
0.8649 High Similarity NPC314682
0.8616 High Similarity NPC1229
0.8609 High Similarity NPC145304
0.8608 High Similarity NPC166014
0.8608 High Similarity NPC230956
0.8608 High Similarity NPC119649
0.8608 High Similarity NPC235143
0.8608 High Similarity NPC205255
0.8608 High Similarity NPC271388
0.8608 High Similarity NPC27410
0.86 High Similarity NPC128019
0.86 High Similarity NPC476567
0.86 High Similarity NPC136860
0.859 High Similarity NPC216459
0.859 High Similarity NPC138487
0.859 High Similarity NPC41178
0.8571 High Similarity NPC298979
0.8571 High Similarity NPC204947
0.8562 High Similarity NPC475959
0.8553 High Similarity NPC80759
0.8553 High Similarity NPC79402
0.8545 High Similarity NPC23219
0.8544 High Similarity NPC7393
0.8544 High Similarity NPC221864
0.8535 High Similarity NPC146288
0.8528 High Similarity NPC239775
0.8519 High Similarity NPC241055
0.8509 High Similarity NPC304659
0.8509 High Similarity NPC86144
0.8503 High Similarity NPC248642
0.8497 Intermediate Similarity NPC476151
0.8494 Intermediate Similarity NPC126284
0.8476 Intermediate Similarity NPC477020
0.8476 Intermediate Similarity NPC66341
0.8476 Intermediate Similarity NPC192135
0.8467 Intermediate Similarity NPC470925
0.8466 Intermediate Similarity NPC477562
0.8466 Intermediate Similarity NPC69712
0.8466 Intermediate Similarity NPC26240
0.8466 Intermediate Similarity NPC118274
0.8466 Intermediate Similarity NPC168753
0.8452 Intermediate Similarity NPC156576
0.8447 Intermediate Similarity NPC168409
0.8443 Intermediate Similarity NPC32413
0.8443 Intermediate Similarity NPC474506
0.8434 Intermediate Similarity NPC148693
0.8434 Intermediate Similarity NPC190461
0.8434 Intermediate Similarity NPC118633
0.8434 Intermediate Similarity NPC294790
0.8428 Intermediate Similarity NPC477080
0.8418 Intermediate Similarity NPC234392
0.8418 Intermediate Similarity NPC180756
0.8418 Intermediate Similarity NPC31311
0.8418 Intermediate Similarity NPC323443
0.8393 Intermediate Similarity NPC116284
0.8387 Intermediate Similarity NPC477565
0.8387 Intermediate Similarity NPC103379
0.8387 Intermediate Similarity NPC44869
0.8385 Intermediate Similarity NPC189470
0.8383 Intermediate Similarity NPC267408
0.8383 Intermediate Similarity NPC220961
0.8383 Intermediate Similarity NPC258695
0.8383 Intermediate Similarity NPC470879
0.8378 Intermediate Similarity NPC11147
0.8373 Intermediate Similarity NPC112575
0.8366 Intermediate Similarity NPC185838
0.8354 Intermediate Similarity NPC2413
0.8354 Intermediate Similarity NPC127674
0.8354 Intermediate Similarity NPC204828
0.8354 Intermediate Similarity NPC249797
0.8354 Intermediate Similarity NPC184026
0.8354 Intermediate Similarity NPC295691
0.8354 Intermediate Similarity NPC276588
0.8354 Intermediate Similarity NPC193949
0.8354 Intermediate Similarity NPC207757
0.8354 Intermediate Similarity NPC278799
0.8354 Intermediate Similarity NPC329911
0.8354 Intermediate Similarity NPC93593
0.8354 Intermediate Similarity NPC469817
0.8354 Intermediate Similarity NPC110416
0.8354 Intermediate Similarity NPC5238
0.8354 Intermediate Similarity NPC39701
0.8354 Intermediate Similarity NPC172765
0.8354 Intermediate Similarity NPC54379
0.8354 Intermediate Similarity NPC189266
0.8344 Intermediate Similarity NPC233029
0.8344 Intermediate Similarity NPC114124
0.8344 Intermediate Similarity NPC210148
0.8343 Intermediate Similarity NPC135772
0.8343 Intermediate Similarity NPC302275
0.8333 Intermediate Similarity NPC179704
0.8333 Intermediate Similarity NPC312918
0.8333 Intermediate Similarity NPC477561
0.8333 Intermediate Similarity NPC476574
0.8333 Intermediate Similarity NPC155442
0.8323 Intermediate Similarity NPC24233
0.8323 Intermediate Similarity NPC476571
0.8323 Intermediate Similarity NPC135538
0.8323 Intermediate Similarity NPC147390
0.8323 Intermediate Similarity NPC246587
0.8323 Intermediate Similarity NPC428
0.8313 Intermediate Similarity NPC477558
0.8304 Intermediate Similarity NPC237579
0.8304 Intermediate Similarity NPC312531
0.8303 Intermediate Similarity NPC227060
0.8303 Intermediate Similarity NPC317439
0.8303 Intermediate Similarity NPC76682
0.8303 Intermediate Similarity NPC10908
0.8303 Intermediate Similarity NPC198498
0.8303 Intermediate Similarity NPC317145
0.8303 Intermediate Similarity NPC63646
0.8303 Intermediate Similarity NPC276890
0.8303 Intermediate Similarity NPC115284
0.8302 Intermediate Similarity NPC247639
0.8302 Intermediate Similarity NPC25084
0.8282 Intermediate Similarity NPC56887
0.8282 Intermediate Similarity NPC476573
0.8282 Intermediate Similarity NPC13916
0.8282 Intermediate Similarity NPC35627
0.8282 Intermediate Similarity NPC193853
0.8282 Intermediate Similarity NPC264850
0.8282 Intermediate Similarity NPC223077

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC244112 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8742 High Similarity NPD4584 Approved
0.8716 High Similarity NPD4664 Clinical (unspecified phase)
0.8313 Intermediate Similarity NPD6788 Approved
0.8303 Intermediate Similarity NPD8251 Approved
0.8303 Intermediate Similarity NPD8252 Approved
0.8303 Intermediate Similarity NPD8099 Discontinued
0.8253 Intermediate Similarity NPD8156 Discontinued
0.8187 Intermediate Similarity NPD6818 Clinical (unspecified phase)
0.8182 Intermediate Similarity NPD5084 Clinical (unspecified phase)
0.8171 Intermediate Similarity NPD3051 Approved
0.816 Intermediate Similarity NPD7201 Clinical (unspecified phase)
0.8072 Intermediate Similarity NPD4481 Phase 3
0.805 Intermediate Similarity NPD4017 Approved
0.8026 Intermediate Similarity NPD6028 Clinical (unspecified phase)
0.8026 Intermediate Similarity NPD6029 Clinical (unspecified phase)
0.8012 Intermediate Similarity NPD7298 Approved
0.8012 Intermediate Similarity NPD2970 Approved
0.8012 Intermediate Similarity NPD2969 Approved
0.7965 Intermediate Similarity NPD8053 Approved
0.7965 Intermediate Similarity NPD8054 Approved
0.7962 Intermediate Similarity NPD2421 Approved
0.7962 Intermediate Similarity NPD2420 Approved
0.7925 Intermediate Similarity NPD6031 Approved
0.7925 Intermediate Similarity NPD6030 Approved
0.7879 Intermediate Similarity NPD7400 Phase 3
0.7867 Intermediate Similarity NPD5718 Phase 2
0.7866 Intermediate Similarity NPD4581 Clinical (unspecified phase)
0.7857 Intermediate Similarity NPD27 Approved
0.7857 Intermediate Similarity NPD2489 Approved
0.7844 Intermediate Similarity NPD6071 Discontinued
0.7826 Intermediate Similarity NPD7261 Clinical (unspecified phase)
0.7818 Intermediate Similarity NPD7832 Clinical (unspecified phase)
0.7818 Intermediate Similarity NPD7831 Phase 2
0.7818 Intermediate Similarity NPD7833 Phase 2
0.7815 Intermediate Similarity NPD4474 Approved
0.7815 Intermediate Similarity NPD4475 Approved
0.7812 Intermediate Similarity NPD3640 Phase 3
0.7812 Intermediate Similarity NPD3639 Approved
0.7812 Intermediate Similarity NPD3641 Approved
0.7805 Intermediate Similarity NPD2560 Approved
0.7805 Intermediate Similarity NPD2563 Approved
0.78 Intermediate Similarity NPD2669 Clinical (unspecified phase)
0.7785 Intermediate Similarity NPD6783 Clinical (unspecified phase)
0.7784 Intermediate Similarity NPD7802 Discontinued
0.7763 Intermediate Similarity NPD3110 Approved
0.7763 Intermediate Similarity NPD3109 Approved
0.7751 Intermediate Similarity NPD2898 Approved
0.7727 Intermediate Similarity NPD7906 Approved
0.7722 Intermediate Similarity NPD5307 Clinical (unspecified phase)
0.7722 Intermediate Similarity NPD5241 Discontinued
0.7702 Intermediate Similarity NPD5976 Discontinued
0.7701 Intermediate Similarity NPD2968 Approved
0.7701 Intermediate Similarity NPD2971 Approved
0.7644 Intermediate Similarity NPD8453 Clinical (unspecified phase)
0.7632 Intermediate Similarity NPD6812 Clinical (unspecified phase)
0.763 Intermediate Similarity NPD6996 Clinical (unspecified phase)
0.7625 Intermediate Similarity NPD7598 Phase 2
0.7622 Intermediate Similarity NPD4772 Phase 2
0.7622 Intermediate Similarity NPD4773 Phase 2
0.7616 Intermediate Similarity NPD5752 Clinical (unspecified phase)
0.7613 Intermediate Similarity NPD6896 Approved
0.7613 Intermediate Similarity NPD6895 Approved
0.76 Intermediate Similarity NPD7313 Approved
0.76 Intermediate Similarity NPD4578 Approved
0.76 Intermediate Similarity NPD7311 Approved
0.76 Intermediate Similarity NPD7312 Approved
0.76 Intermediate Similarity NPD7310 Approved
0.76 Intermediate Similarity NPD4577 Approved
0.7595 Intermediate Similarity NPD4236 Phase 3
0.7595 Intermediate Similarity NPD4237 Approved
0.7578 Intermediate Similarity NPD1424 Approved
0.7571 Intermediate Similarity NPD4663 Approved
0.7569 Intermediate Similarity NPD7667 Clinical (unspecified phase)
0.7562 Intermediate Similarity NPD3845 Phase 1
0.7562 Intermediate Similarity NPD7124 Phase 2
0.7557 Intermediate Similarity NPD7309 Approved
0.7529 Intermediate Similarity NPD4010 Discontinued
0.7529 Intermediate Similarity NPD4166 Phase 2
0.7516 Intermediate Similarity NPD3124 Discontinued
0.75 Intermediate Similarity NPD6523 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD4055 Discovery
0.7485 Intermediate Similarity NPD5978 Approved
0.7485 Intermediate Similarity NPD5977 Approved
0.7446 Intermediate Similarity NPD8095 Phase 1
0.7438 Intermediate Similarity NPD6748 Discontinued
0.7438 Intermediate Similarity NPD5754 Discontinued
0.7399 Intermediate Similarity NPD5602 Clinical (unspecified phase)
0.7391 Intermediate Similarity NPD4420 Approved
0.7368 Intermediate Similarity NPD6107 Approved
0.7348 Intermediate Similarity NPD2488 Approved
0.7348 Intermediate Similarity NPD2490 Approved
0.7337 Intermediate Similarity NPD2973 Approved
0.7337 Intermediate Similarity NPD2974 Approved
0.7337 Intermediate Similarity NPD2975 Approved
0.7333 Intermediate Similarity NPD4210 Discontinued
0.7329 Intermediate Similarity NPD7466 Approved
0.7326 Intermediate Similarity NPD6747 Phase 1
0.7312 Intermediate Similarity NPD7045 Clinical (unspecified phase)
0.7312 Intermediate Similarity NPD7037 Approved
0.7305 Intermediate Similarity NPD7110 Phase 1
0.7305 Intermediate Similarity NPD7109 Clinical (unspecified phase)
0.7283 Intermediate Similarity NPD6687 Approved
0.7283 Intermediate Similarity NPD6688 Approved
0.7267 Intermediate Similarity NPD5177 Phase 3
0.7267 Intermediate Similarity NPD3060 Approved
0.7256 Intermediate Similarity NPD1754 Clinical (unspecified phase)
0.7239 Intermediate Similarity NPD2422 Clinical (unspecified phase)
0.7238 Intermediate Similarity NPD7291 Discontinued
0.7237 Intermediate Similarity NPD7258 Clinical (unspecified phase)
0.7234 Intermediate Similarity NPD5005 Approved
0.7234 Intermediate Similarity NPD5006 Approved
0.7232 Intermediate Similarity NPD6297 Approved
0.7222 Intermediate Similarity NPD6658 Clinical (unspecified phase)
0.7219 Intermediate Similarity NPD4580 Approved
0.7219 Intermediate Similarity NPD5773 Approved
0.7219 Intermediate Similarity NPD5772 Approved
0.7215 Intermediate Similarity NPD4579 Clinical (unspecified phase)
0.7212 Intermediate Similarity NPD5261 Clinical (unspecified phase)
0.7212 Intermediate Similarity NPD3647 Clinical (unspecified phase)
0.7212 Intermediate Similarity NPD6090 Discontinued
0.7209 Intermediate Similarity NPD5677 Discontinued
0.7207 Intermediate Similarity NPD3534 Clinical (unspecified phase)
0.7207 Intermediate Similarity NPD5917 Clinical (unspecified phase)
0.7193 Intermediate Similarity NPD5604 Discontinued
0.7186 Intermediate Similarity NPD4005 Discontinued
0.7181 Intermediate Similarity NPD3452 Approved
0.7181 Intermediate Similarity NPD3450 Approved
0.7181 Intermediate Similarity NPD2494 Approved
0.7181 Intermediate Similarity NPD2493 Approved
0.7179 Intermediate Similarity NPD7294 Phase 1
0.7176 Intermediate Similarity NPD5616 Clinical (unspecified phase)
0.7171 Intermediate Similarity NPD1669 Approved
0.7169 Intermediate Similarity NPD6662 Clinical (unspecified phase)
0.7169 Intermediate Similarity NPD1914 Approved
0.7169 Intermediate Similarity NPD4727 Phase 1
0.7152 Intermediate Similarity NPD4123 Phase 3
0.7152 Intermediate Similarity NPD7019 Approved
0.7152 Intermediate Similarity NPD7020 Approved
0.7151 Intermediate Similarity NPD5709 Phase 3
0.7134 Intermediate Similarity NPD554 Clinical (unspecified phase)
0.7134 Intermediate Similarity NPD6666 Approved
0.7134 Intermediate Similarity NPD6667 Approved
0.7127 Intermediate Similarity NPD5087 Clinical (unspecified phase)
0.7119 Intermediate Similarity NPD5312 Approved
0.7119 Intermediate Similarity NPD5313 Approved
0.7118 Intermediate Similarity NPD4585 Approved
0.7118 Intermediate Similarity NPD2978 Approved
0.7118 Intermediate Similarity NPD2977 Approved
0.7117 Intermediate Similarity NPD6331 Phase 2
0.7117 Intermediate Similarity NPD3977 Clinical (unspecified phase)
0.711 Intermediate Similarity NPD4666 Phase 3
0.711 Intermediate Similarity NPD6037 Discontinued
0.7091 Intermediate Similarity NPD5297 Approved
0.7081 Intermediate Similarity NPD1632 Clinical (unspecified phase)
0.7072 Intermediate Similarity NPD6853 Approved
0.7072 Intermediate Similarity NPD6851 Approved
0.7068 Intermediate Similarity NPD4583 Approved
0.7068 Intermediate Similarity NPD4582 Approved
0.7066 Intermediate Similarity NPD7427 Discontinued
0.7063 Intermediate Similarity NPD6111 Discontinued
0.7063 Intermediate Similarity NPD7718 Clinical (unspecified phase)
0.7059 Intermediate Similarity NPD5720 Discontinued
0.7059 Intermediate Similarity NPD7945 Clinical (unspecified phase)
0.7055 Intermediate Similarity NPD4162 Approved
0.7048 Intermediate Similarity NPD7447 Phase 1
0.7041 Intermediate Similarity NPD6876 Approved
0.7041 Intermediate Similarity NPD6875 Approved
0.7037 Intermediate Similarity NPD4107 Approved
0.7032 Intermediate Similarity NPD7905 Discontinued
0.7022 Intermediate Similarity NPD4873 Discontinued
0.7017 Intermediate Similarity NPD7281 Phase 3
0.7017 Intermediate Similarity NPD7280 Phase 3
0.7016 Intermediate Similarity NPD4004 Approved
0.7016 Intermediate Similarity NPD4002 Approved
0.7007 Intermediate Similarity NPD5283 Phase 1
0.7006 Intermediate Similarity NPD5156 Approved
0.7006 Intermediate Similarity NPD5938 Phase 3
0.7006 Intermediate Similarity NPD5155 Approved
0.7 Intermediate Similarity NPD2492 Phase 1
0.7 Intermediate Similarity NPD6386 Approved
0.7 Intermediate Similarity NPD7438 Suspended
0.7 Intermediate Similarity NPD6385 Approved
0.6994 Remote Similarity NPD1372 Clinical (unspecified phase)
0.6988 Remote Similarity NPD7213 Phase 3
0.6988 Remote Similarity NPD7212 Phase 2
0.6983 Remote Similarity NPD3920 Phase 2
0.6983 Remote Similarity NPD7479 Phase 2
0.6981 Remote Similarity NPD2238 Phase 2
0.6978 Remote Similarity NPD6618 Phase 2
0.6978 Remote Similarity NPD7090 Clinical (unspecified phase)
0.6973 Remote Similarity NPD6656 Clinical (unspecified phase)
0.697 Remote Similarity NPD3301 Approved
0.697 Remote Similarity NPD5160 Discontinued
0.6968 Remote Similarity NPD4098 Discontinued
0.6968 Remote Similarity NPD7034 Discontinued
0.6968 Remote Similarity NPD5564 Approved
0.6966 Remote Similarity NPD7177 Discontinued
0.6964 Remote Similarity NPD2122 Discontinued
0.6961 Remote Similarity NPD7549 Discontinued
0.6961 Remote Similarity NPD7190 Clinical (unspecified phase)

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data